BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38703829)

  • 1. Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network.
    Segovia-Zafra A; Villanueva-Paz M; Serras AS; Matilla-Cabello G; Bodoque-García A; Di Zeo-Sánchez DE; Niu H; Álvarez-Álvarez I; Sanz-Villanueva L; Godec S; Milisav I; Bagnaninchi P; Andrade RJ; Lucena MI; Fernández-Checa JC; Cubero FJ; Miranda JP; Nelson LJ
    J Hepatol; 2024 May; ():. PubMed ID: 38703829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced preclinical models for evaluation of drug-induced liver injury - consensus statement by the European Drug-Induced Liver Injury Network [PRO-EURO-DILI-NET].
    Fernandez-Checa JC; Bagnaninchi P; Ye H; Sancho-Bru P; Falcon-Perez JM; Royo F; Garcia-Ruiz C; Konu O; Miranda J; Lunov O; Dejneka A; Elfick A; McDonald A; Sullivan GJ; Aithal GP; Lucena MI; Andrade RJ; Fromenty B; Kranendonk M; Cubero FJ; Nelson LJ
    J Hepatol; 2021 Oct; 75(4):935-959. PubMed ID: 34171436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current limitations and future opportunities for prediction of DILI from in vitro.
    Funk C; Roth A
    Arch Toxicol; 2017 Jan; 91(1):131-142. PubMed ID: 27766365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatotoxicity reports in the FDA adverse event reporting system database: A comparison of drugs that cause injury
    Rana P; Aleo MD; Wen X; Kogut S
    Acta Pharm Sin B; 2021 Dec; 11(12):3857-3868. PubMed ID: 35024312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A human liver organoid screening platform for DILI risk prediction.
    Zhang CJ; Meyer SR; O'Meara MJ; Huang S; Capeling MM; Ferrer-Torres D; Childs CJ; Spence JR; Fontana RJ; Sexton JZ
    J Hepatol; 2023 May; 78(5):998-1006. PubMed ID: 36738840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current challenges and controversies in drug-induced liver injury.
    Corsini A; Ganey P; Ju C; Kaplowitz N; Pessayre D; Roth R; Watkins PB; Albassam M; Liu B; Stancic S; Suter L; Bortolini M
    Drug Saf; 2012 Dec; 35(12):1099-117. PubMed ID: 23137150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Detection of Drug-Induced Liver Injury by Integrating Predicted
    Seal S; Williams DP; Hosseini-Gerami L; Mahale M; Carpenter AE; Spjuth O; Bender A
    bioRxiv; 2024 Jun; ():. PubMed ID: 38895462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man.
    Dragovic S; Vermeulen NP; Gerets HH; Hewitt PG; Ingelman-Sundberg M; Park BK; Juhila S; Snoeys J; Weaver RJ
    Arch Toxicol; 2016 Dec; 90(12):2979-3003. PubMed ID: 27659300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Battery of
    Rathman J; Yang C; Ribeiro JV; Mostrag A; Thakkar S; Tong W; Hobocienski B; Sacher O; Magdziarz T; Bienfait B
    Chem Res Toxicol; 2021 Feb; 34(2):601-615. PubMed ID: 33356149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work.
    Suzuki A; Andrade RJ; Bjornsson E; Lucena MI; Lee WM; Yuen NA; Hunt CM; Freston JW
    Drug Saf; 2010 Jun; 33(6):503-22. PubMed ID: 20486732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-Induced Liver Injury: Highlights of the Recent Literature.
    Real M; Barnhill MS; Higley C; Rosenberg J; Lewis JH
    Drug Saf; 2019 Mar; 42(3):365-387. PubMed ID: 30343418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers of idiosyncratic drug-induced liver injury (DILI) - a systematic review.
    Atallah E; Freixo C; Alvarez-Alvarez I; Cubero FJ; Gerbes AL; Kullak-Ublick GA; Aithal GP
    Expert Opin Drug Metab Toxicol; 2021 Nov; 17(11):1327-1343. PubMed ID: 34727797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Application of a Transcriptomic Signature of Bioactivation in an Advanced In Vitro Liver Model to Reduce Drug-induced Liver Injury Risk Early in the Pharmaceutical Pipeline.
    Kang W; Podtelezhnikov AA; Tanis KQ; Pacchione S; Su M; Bleicher KB; Wang Z; Laws GM; Griffiths TG; Kuhls MC; Chen Q; Knemeyer I; Marsh DJ; Mitra K; Lebron J; Sistare FD
    Toxicol Sci; 2020 Sep; 177(1):121-139. PubMed ID: 32559289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of in vitro combination assays of mitochondrial dysfunction and apoptosis for the estimation of potential risk of idiosyncratic drug induced liver injury.
    Goda K; Takahashi T; Kobayashi A; Shoda T; Kuno H; Sugai S
    J Toxicol Sci; 2016; 41(5):605-15. PubMed ID: 27665770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism-based integrated assay systems for the prediction of drug-induced liver injury.
    Kawaguchi M; Nukaga T; Sekine S; Takemura A; Susukida T; Oeda S; Kodama A; Hirota M; Kouzuki H; Ito K
    Toxicol Appl Pharmacol; 2020 May; 394():114958. PubMed ID: 32198022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction models for drug-induced hepatotoxicity by using weighted molecular fingerprints.
    Kim E; Nam H
    BMC Bioinformatics; 2017 May; 18(Suppl 7):227. PubMed ID: 28617228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Setting Clinical Exposure Levels of Concern for Drug-Induced Liver Injury (DILI) Using Mechanistic in vitro Assays.
    Shah F; Leung L; Barton HA; Will Y; Rodrigues AD; Greene N; Aleo MD
    Toxicol Sci; 2015 Oct; 147(2):500-14. PubMed ID: 26206150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of liver injury induced by chemicals in human with a multiparametric assay on isolated mouse liver mitochondria.
    Porceddu M; Buron N; Roussel C; Labbe G; Fromenty B; Borgne-Sanchez A
    Toxicol Sci; 2012 Oct; 129(2):332-45. PubMed ID: 22987451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
    Liu Z; Shi Q; Ding D; Kelly R; Fang H; Tong W
    PLoS Comput Biol; 2011 Dec; 7(12):e1002310. PubMed ID: 22194678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.